Spot no. | Specificity N10: N20 | Matched peptide sequences | Sequence coveragea) | Mascot scoreb) | Mrgel/Mrpredicted | pI gel/pI predicted | SP Length | PP Length | Putative function (symbolic name) |
---|---|---|---|---|---|---|---|---|---|
Proteolytic enzymes | |||||||||
36 | 0.3* | 1. VVAGEHSLR 2. SVDVPVVDDDTCNR | 8.9% | 149 | 30/26–29 | 4.4/4.4–4.8 | 15 | 27 | Trypsin (TRY5L) |
1. LTAAEEPTRVEIR 2. IRNDVALIK | 7.5% | 80 | 30/25–30 | 4.4/4.5–5.3 | 18 | 48 | Chymotrypsin (CHY1A) | ||
37 | 0.2* | 1. GVTDLTIFR 2. VVAGEHSLR 3. VVAGEHSLRTDSGLEQNR | 9.8% | 159 | 29/26–29 | 4.4/4.4–4.8 | 15 | 27 | Trypsin (TRY5F) |
1. VVAGEHSLR 2. SVDVPVVDDDTCNR | 8.9% | 149 | 29/26–29 | 4.4/4.4–4.8 | 15 | 27 | Trypsin (TRY5L) | ||
38 | 0.5* | 1. GLADADIAVFK 2. LIWMGQYNR 3. YYRDELAGK | 10.7% | 123 | 29/30 | 4.5/4.5 | 19 | Endoribonuclease-like protein (ERNA) | |
1. GLADADIAVFK 2. LIWMGQYNR 3. YYRDELAGK | 8.0% | 123 | 29/39 | 4.5/4.6 | 20 | Endoribonuclease-like protein (ERNB) | |||
1. VVAGEHSLR 2. SVDVPVVDDDTCNR | 8.9% | 149 | 29/26–29 | 4.5/4.4–4.8 | 15 | 27 | Trypsin (TRY5L) | ||
1. GVTDLTIFR 2. VVAGEHSLR | 6.5% | 80 | 29/26–29 | 4.5/4.4–4.8 | 15 | 27 | Trypsin (TRY5F) | ||
39 | 0.4* | 1. VVAGEHSLR 2. SVDVPVVDDDTCNR | 8.9% | 149 | 29/26–29 | 4.6/4.4–4.8 | 15 | 27 | Trypsin (TRY5L) |
1. GVTDLTIFR 2. VVAGEHSLR | 6.5% | 120 | 29/26–29 | 4.6/4.4–4.8 | 15 | 27 | Trypsin (TRY5F) | ||
40 | 0.6* | 1. TTEEYYVSVQK 2. TGGGCYSYIGR | 6.5% | 112 | 25/23–27 | 4.5/4.7–4.6 | ? | 39 ? | Astacin (ACN2) |
1. GVTDLTIFR 2. VVAGEHSLR | 6.5% | 109 | 25/26–29 | 4.5/4.4–4.8 | 15 | 27 | Trypsin (TRY5F) | ||
41 | 0.4* | 1. LTAAEEPTR 2. LTAAEEPTRVEVR 3. IINDVALIK | 9.1% | 141 | 25/25–30 | 4.7/4.4–5.0 | 18 | 47 | Chymotrypsin (CHY1C) |
28 | 1.2 | see [12] | Peptidase M13 Peptidase M2 Carboxylesterase, type B Sphingomyelin phosphodiesterase Sphingomyelin phosphodiesterase | ||||||
31 | 0.6 | see [12] | 30/34–45 30/35–46 29/26–29 | 4.8/4.9–4.8 4.8/5.1–4.9 4.4/4.4–4.8 | 16 16 15 | 92 93 27 | Carboxypeptidase A (CPA1A) Carboxypeptidase A (CPA1B) Trypsin (TRY5F) | ||
32 | 0.3 | see [12] | 23/24–27 | 5.0/5.2–5.4 | 17 | 24 | Trypsin (TRY4B) | ||
Egg yolk proteins & precursors | |||||||||
43 | 7.3* | see Figure 2 | /190–220 | /6.4–6.7 | 17–20 | Vitellogenin (VTG1, VTG2, VTG4) | |||
44 | 7.1* | see Figure 3 see Figure 2 | 15.7% 2.8% | 271 | 25/42 25/220 | 5.8/5.3 5.8/6.7 | 17 17 | Actin Vitellogenin (VTG1) | |
45 | 5.9* | see Figure 2 | 2.2% | 132 | 21/190 | 5.2/6.4 | 20 | Vitellogenin (VTG4) | |
46 | 5.2* | see Figure 2 | 2.9% | 361 | 21/220 | 5.9/6.7 | 17 | Vitellogenin (VTG1) | |
47 | 4.9* | see Figure 3 see Figure 2 | 9.6% 2.0% | 25/42 25/220 | 5.6/5.3 5.6/6.7 | 17 | Actin Vitellogenin (VTG1, VTG2) | ||
1. EDQMDYLEEK 2. LLVEKER 3. YSVDEELNK | 3.6% | 25/83 | 5.6/4.7 | HSP90 | |||||
49 | 4.4* | see Figure 2 | ?.?% | ??? | 21/190–220 | 4.8/6.4–6.7 | 17–20 | Vitellogenin (VTG1, VTG2, VTG4) | |
50 | 4.2* | see Figure 2 | 2.2% | 163 | 20/220 | 5.7/6.7 | 17 | Vitellogenin (VTG1) | |
52 | 3.7 | see Figure 2 | 3.0% | 344 | 18/220 | 5.1/6.7 | 17 | Vitellogenin (VTG1, VTG2) | |
Cytoskeleton & muscle proteins | |||||||||
48 | 4.5* | see Figure 2 see Figure 3 | ?.?% | ??? | 27/42 | 5.2/5.3 | Actin Vitellogenin (VTG4) | ||
1. EQLDEESEAK 2. AEELEDAKR 3. ATVLANQMEK | 27/220 | 5.2/5.9 | Myosin heavy chain (MHC-1) | ||||||
1. LTTDPAFLEK 2. NAAAVHEIR 3. GDLGIEIPPEK | 27/?? | 5.2/? | Pyruvate kinase | ||||||
51 | 3.6* | see Figure 3 | ?.?% | ??? | 36/42 | 5.7/5.3 | Actin | ||
ATPase | |||||||||
42 | 9.8* | 2. GNEDLSTAILK 3. MDELQLFK 4. GDIFIVR 5. KQLALIK 6. EMVELPLR | 5.1% | 214 | 16/89 | 5.3/5.0 | AAA+ ATPase | ||
Carbohydrate-modifying enzymes | |||||||||
35 | 1.2 | see [12] | α-Amylase (AMY) | ||||||
34 | 1.0 | see [12] | Exo-β-1,3-Glucanase (EXG5) | ||||||
1 | 0.4 | see [12] | Cellubiohydrolase (CEL7A) | ||||||
29 | 0.3 | see [12] | Endo-β-1,4-Glucanase (CEL9A) Paramyosin (PMY) | ||||||
30 | 0.6 | see [12] | Endo-β-1,4-Mannanase (MAN5A) β-1,3-Glucan-binding protein | ||||||
19 | 0.6 | see [12] | Enolase (ENO) |